Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Small cell carcinoma of the prostate: a case report].
Yamamoto N, Kinoshita H, Inoue T, Kawakita S, Oguchi N, Muguruma K, Kawa G, Sakaguchi Y, Adachi Y, Sakaida N, Uemura Y, Matsuda T. Yamamoto N, et al. Hinyokika Kiyo. 2007 Sep;53(9):665-9. Hinyokika Kiyo. 2007. PMID: 17933147 Free article. Review. Japanese.
Novel mutation (L157X) in the succinate dehydrogenase B gene (SDHB) in a Japanese family with abdominal paraganglioma following lung metastasis.
Saito T, Saito Y, Matsumura K, Tsubota Y, Maniwa T, Kaneda H, Minami K, Sakaida N, Uemura Y, Kawa G, Yamamoto N, Fujii Y, Isobe K, Kawakami Y, Matsuda T, Takekoshi K. Saito T, et al. Among authors: yamamoto n. Endocr J. 2009;56(3):451-8. doi: 10.1507/endocrj.k08e-178. Epub 2009 Mar 3. Endocr J. 2009. PMID: 19261994 Free article.
Asymptomatic neuro-Behçet's disease.
Shimojo S, Yamamoto N, Matsuda T, Yukinari T. Shimojo S, et al. Among authors: yamamoto n. J Neuroimaging. 1998 Jan;8(1):59-60. doi: 10.1111/jon19988159. J Neuroimaging. 1998. PMID: 9442598 No abstract available.
Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing's syndrome.
Tsujimoto Y, Yamamoto N, Bando H, Yamamoto M, Ohmachi Y, Motomura Y, Oi-Yo Y, Sasaki Y, Suzuki M, Urai S, Takahashi M, Iguchi G, Ogawa W, Fukuoka H. Tsujimoto Y, et al. Among authors: yamamoto n. Front Endocrinol (Lausanne). 2024 Dec 23;15:1511155. doi: 10.3389/fendo.2024.1511155. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39764253 Free PMC article.
Prostate Cancer Patient With Lymph-node Metastasis Treated Only With Methionine Restriction Has Stable Disease for Two Years Demonstrated With PET/CT and PSMA-PET Scanning and PSA Testing.
Morinaga S, Han Q, Mizuta K, Kang BM, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: yamamoto n. Cancer Diagn Progn. 2025 Jan 3;5(1):27-31. doi: 10.21873/cdp.10408. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758238 Free PMC article.
Elevated-c-MYC-expressing Fibrosarcoma Cells With Acquired Gemcitabine Resistance Remain Sensitive to Recombinant Methioninase: A Potential Clinical Strategy for a Recalcitrant Disease.
Morinaga S, Han Q, Mizuta K, Kang BM, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: yamamoto n. Cancer Diagn Progn. 2025 Jan 3;5(1):8-14. doi: 10.21873/cdp.10405. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758233 Free PMC article.
Complete Response (CR) in a Previously-progressing Chronic Lymphocytic Leukemia (CLL) Patient Treated With Methionine Restriction in Combination With First-line Chemotherapy.
Morinaga S, Han Q, Mizuta K, Kang BM, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: yamamoto n. Cancer Diagn Progn. 2025 Jan 3;5(1):21-26. doi: 10.21873/cdp.10407. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758229 Free PMC article.
6,408 results